Cargando…
Embryonic Stem Cell-Derived Cardiomyocyte Heterogeneity and the Isolation of Immature and Committed Cells for Cardiac Remodeling and Regeneration
Pluripotent stem cells represent one promising source for cell replacement therapy in heart, but differentiating embryonic stem cell-derived cardiomyocytes (ESC-CMs) are highly heterogeneous and show a variety of maturation states. In this study, we employed an ESC clonal line that contains a cardia...
Autores principales: | Boheler, Kenneth R., Joodi, Robert N., Qiao, Hui, Juhasz, Ondrej, Urick, Amanda L., Chuppa, Sandra L., Gundry, Rebekah L., Wersto, Robert P., Zhou, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168772/ https://www.ncbi.nlm.nih.gov/pubmed/21912557 http://dx.doi.org/10.4061/2011/214203 |
Ejemplares similares
-
Enhanced Proliferation of Monolayer Cultures of Embryonic Stem (ES) Cell-Derived Cardiomyocytes Following Acute Loss of Retinoblastoma
por: Yamanaka, Satoshi, et al.
Publicado: (2008) -
A Human Pluripotent Stem Cell Surface N-Glycoproteome Resource Reveals Markers, Extracellular Epitopes, and Drug Targets
por: Boheler, Kenneth R., et al.
Publicado: (2014) -
Concise Review: Cell Surface N‐Linked Glycoproteins as Potential Stem Cell Markers and Drug Targets
por: Boheler, Kenneth R., et al.
Publicado: (2016) -
Importance of evaluating protein glycosylation in pluripotent stem cell-derived cardiomyocytes for research and clinical applications
por: Kelly, Maia I., et al.
Publicado: (2021) -
Are These Cardiomyocytes? Protocol Development Reveals Impact of Sample Preparation on the Accuracy of Identifying Cardiomyocytes by Flow Cytometry
por: Waas, Matthew, et al.
Publicado: (2019)